Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver.
Multipotent mesenchymal stromal cells (MSC) are currently investigated clinically as cellular therapy for a variety of diseases. Differentiation of MSC toward endodermal lineages, including hepatocytes and their therapeutic effect on fibrosis has been described but remains controversial. Recent evidence attributed a fibrotic potential to MSC. As differentiation potential might be dependent of donor age, we studied MSC derived from adult and pediatric human bone marrow and their potential to differentiate into hepatocytes or myofibroblasts in vitro and in vivo. Following characterization, expanded adult and pediatric MSC were co-cultured with a human hepatoma cell line, Huh-7, in a hepatogenic differentiation medium containing Hepatocyte growth factor, Fibroblast growth factor 4 and oncostatin M. In vivo, MSC were transplanted into spleen or liver of NOD/SCID mice undergoing partial hepatectomy and retrorsine treatment. Expression of mesenchymal and hepatic markers was analyzed by RT-PCR, Western blot and immunohistochemistry. In vitro, adult and pediatric MSC expressed characteristic surface antigens of MSC. Expansion capacity of pediatric MSC was significantly higher when compared to adult MSC. In co-culture with Huh-7 cells in hepatogenic differentiation medium, albumin expression was more frequently detected in pediatric MSC (5/8 experiments) when compared to adult MSC (2/10 experiments). However, in such condition pediatric MSC expressed alpha smooth muscle more strongly than adult MSC. Stable engraftment in the liver was not achieved after intrasplenic injection of pediatric or adult MSC. After intrahepatic injection, MSC permanently remained in liver tissue, kept a mesenchymal morphology and expressed vimentin and alpha smooth muscle actin, but no hepatic markers. Further, MSC localization merges with collagen deposition in transplanted liver and no difference was observed using adult or pediatric MSC. In conclusion, when transplanted into an injured or regenerating liver, MSC differentiated into myofibroblasts with development of fibrous tissue, regardless of donor age. These results indicate that MSC in certain circumstances might be harmful due to their fibrogenic potential and this should be considered before potential use of MSC for cell therapy.
Baertschiger
Reto M
RM
Surgical Research Unit, Department of Surgery, University Hospital Geneva, Geneva, Switzerland.
Serre-Beinier
Véronique
V
Morel
Philippe
P
Bosco
Domenico
D
Peyrou
Marion
M
Clément
Sophie
S
Sgroi
Antonino
A
Kaelin
André
A
Buhler
Leo H
LH
Gonelle-Gispert
Carmen
C
D000199:Actins / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D002454:Cell Differentiation; D003094:Collagen / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D008099:Liver / Q000378:metabolism / Q000473:pathology*; D008103:Liver Cirrhosis / Q000473:pathology*; D008648:Mesoderm / Q000166:cytology*; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017154:Stromal Cells / Q000166:cytology*
D000199:Actins; D003094:Collagen
Mech Ageing Dev. 2008 Mar;129(3):163-73
18241911
Stem Cells. 2004;22(5):675-82
15342932
J Cell Biol. 1986 Dec;103(6 Pt 2):2787-96
3539945
Biochem Biophys Res Commun. 2005 May 20;330(4):1153-61
15823564
Aging Cell. 2006 Jun;5(3):213-24
16842494
Hepatology. 2000 Jul;32(1):11-6
10869283
Gastroenterology. 2008 Mar;134(3):833-48
18243183
Nature. 1970 Aug 15;227(5259):680-5
5432063
Blood. 2005 Jul 15;106(2):756-63
15817682
Cytotherapy. 2005;7(5):393-5
16236628
Am J Pathol. 1998 Jul;153(1):319-29
9665494
Pancreas. 2008 Jul;37(1):75-84
18580448
Gastroenterology. 2006 May;130(6):1807-21
16697743
Stem Cells. 2007 Mar;25(3):639-45
17110617
Stem Cells. 2008 Mar;26(3):789-97
18065393
Protein Sci. 2007 Nov;16(11):2531-41
17905828
J Clin Invest. 2002 May;109(10):1291-302
12021244
Stem Cells. 2007 Nov;25(11):2739-49
17656645
J Hepatol. 2005 Dec;43(6):1031-7
16169114
Hepatology. 2004 Dec;40(6):1275-84
15562440
Exp Hematol. 1974;2(2):83-92
4455512
Mol Ther. 2008 Jan;16(1):187-93
17955022
Cell Tissue Res. 2007 Mar;327(3):463-70
17093919
Stem Cells. 2007 Mar;25(3):646-54
17124009
J Hepatol. 2006 Apr;44(4):742-8
16469408
Gut. 2008 Feb;57(2):223-31
17639088
J Gastroenterol Hepatol. 2001 Nov;16(11):1244-53
11903743
Stem Cells. 2008 May;26(5):1307-14
18308943
Nature. 2000 Jul 20;406(6793):257
10917519
J Biol Chem. 2008 May 9;283(19):13108-15
18332148
Gut. 2007 Mar;56(3):405-15
16928726
Transplantation. 2006 May 27;81(10):1390-7
16732175
Nucleic Acids Res. 2007;35(22):7557-65
18160407
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1441-6
9037072
Stem Cells. 2006 Apr;24(4):928-35
16306150
J Cell Physiol. 2004 Jan;198(1):110-8
14584050
J Cell Biol. 1993 Jul;122(1):103-11
8314838
Hepatology. 2007 Jul;46(1):219-28
17596885
Nat Med. 1999 Mar;5(3):309-13
10086387
N Engl J Med. 2002 Mar 7;346(10):738-46
11882729
Stem Cells. 2007 Jan;25(1):220-7
16960135
J Viral Hepat. 2008 Jul;15(7):508-14
18397225
Cancer Res. 2007 Oct 1;67(19):9142-9
17909019
Biochem Biophys Res Commun. 2005 Mar 4;328(1):258-64
15670778
Biol Blood Marrow Transplant. 2007 Apr;13(4):412-22
17382248
J Invest Surg. 2003 Mar-Apr;16(2):99-102
12746193
Proc Natl Acad Sci U S A. 1983 Apr;80(8):2361-4
6340120
World J Gastroenterol. 2005 Aug 7;11(29):4497-504
16052678
Gastroenterology. 2004 Apr;126(4):955-63
15057733